American Society of Hematology Annual Meeting, ASCT, Comissão Europeia, companhia farmacêutica, Craig Tendler, daratumumab, Darzalex, dexametasona, doentes adultos, fase 3, Grupo Johnson & Johnson, Janssen, lenalidomida, Maia, mieloma múltiplo, rotator, The New England Journal of Medicine, Thierry Facon Restricted content
adalimumab, biológico, Takeda, The New England Journal of Medicine, Varsity, Vedolizumab Restricted content
cura, Detective, fase III, Gather, GSK, malária, Medicines, P.vivax, Plasmodium vivax, resultados positivos, tafenoquina, The New England Journal of Medicine Restricted content